$LJPC at breakout. $10.90 called Oct 2013 O/
Post# of 63699
called Oct 2013
O/S shares 4,404,407 1/14/14
La Jolla Pharmaceutical Company Reports Positive,
Top-Line Results from Phase 2 Clinical Trial of GCS-100 in Chronic Kidney Disease
3/10/2014 4:15:00 PM - Business Wire